Sanofi Benefits From Stockpiling In Q1, Predicts Long-Term Uplift In Supplements Demand

27 Apr 2020

Sanofi benefits from coronavirus-triggered stockpiling in Q1, with Consumer Healthcare head Alan Main suggesting the pandemic may have turned more consumers into regular dietary supplement users

Stockpiling of pain relief and cough/cold OTCs globally at the beginning of the coronavirus pandemic helped lift Sanofi’s Consumer Healthcare sales by 4.2% at constant exchange rates to €1.3bn ($1.4bn) in the first quarter of 2020.

Sanofi CEO Paul Hudson said “COVID-related pantry loading” had contributed 6 percentage points of growth to Consumer Healthcare’s first quarter...